1181517

Kenvue Brands LLC — FEI 2510184

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 7, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fort Washington, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)